Study to Compare the Effectiveness of Rivaroxaban (Xarelto) Versus Low-molecular-weight Heparin (LMWH) and Phenprocoumon for the Treatment and Secondary Prevention of Venous Thromboembolism in Routine Clinical Practice in Germany
N/A
Researcher in this study want to compare the effectiveness of Rivaroxaban (...
Anti-inflammatory and Anti-thrombotic Therapy With colcHicine and Low Dose Rivaroxaban for Major Adverse Cardiovascular Events Reduction in Ischemic Stroke
PHASE4
The ARCHIMEDES study (Anti-inflammatory and anti-thRombotic therapy with co...
Rivaroxaban Once Daily Versus Dose-adjusted Vitamin K Antagonist on the Biomarkers in Acute Decompensated Heart Failure and Atrial Fibrillation (ROAD HF-AF)
PHASE4
Vitamin K antagonists (VKAs) are used to reduce the risk of stroke (cerebra...
Status
Unknown
Location
Division of Cardiology, Severance Cardiovascular Hospital, Yonsei University College of Medicine
An Observational Study Called H2H-OSCAR-US to Learn More About How Well Rivaroxaban Works and How Safe it is Compared to Apixaban Under Real World Conditions in People in the US With Cancer Who Have Problems Due to Formation of Blood Clots in the Veins (Venous Thromboembolism)
N/A
This is an observational study in which patient data from the past on venou...